Image pharmaphorum Editor Sales & Marketing Sponsored The Science of Healthcare Congresses Overview Views & Analysis Leveraging the FAIR principles of data in pharma The new FAIR guidelines aim to help pharma realise the full potential of data. Views & Analysis De-busting the myths about medical cannabis Medical cannabis has quickly become the most socially disruptive phenomenon of the new millennium, and it is showing no signs of slowing. Views & Analysis How new technologies are creating new markets Sarah Rickwood looks at why the next frontier for pharmaceutical innovation may not be a pharmaceutical at all, and how this will affect launch Load more results
Views & Analysis Leveraging the FAIR principles of data in pharma The new FAIR guidelines aim to help pharma realise the full potential of data.
Views & Analysis De-busting the myths about medical cannabis Medical cannabis has quickly become the most socially disruptive phenomenon of the new millennium, and it is showing no signs of slowing.
Views & Analysis How new technologies are creating new markets Sarah Rickwood looks at why the next frontier for pharmaceutical innovation may not be a pharmaceutical at all, and how this will affect launch
News EU clears first drug therapy for rare disease cALD Neuraxpharm and Minoryx' Nezglyal has become the first approved drug therapy in the EU for rare neurodegenerative disease cALD.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
